HMGB1 and systemic lupus erythematosus: In particular, in SLE patients, serum HMGB1 levels correlated with systemic lupus erythematosus disease activity index (SLEDAI), proteinuria, and anti-ds-DNA antibodies, showing a negative correlation with complement C3 [19, 22].